Your browser doesn't support javascript.
loading
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC.
Dogan, Izzet; Gurbuz, Mustafa; Paksoy, Nail; Ferhatoglu, Ferhat; Vatansever, Sezai; Saip, Pinar; Demirkazik, Ahmet; Aydiner, Adnan.
Afiliação
  • Dogan I; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
  • Gurbuz M; Ankara University Faculty of Medicine, Medical Oncology, Ankara, Turkey.
  • Paksoy N; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
  • Ferhatoglu F; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
  • Vatansever S; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
  • Saip P; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
  • Demirkazik A; Ankara University Faculty of Medicine, Medical Oncology, Ankara, Turkey.
  • Aydiner A; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
Medicine (Baltimore) ; 101(34): e30188, 2022 Aug 26.
Article em En | MEDLINE | ID: mdl-36042659
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article